SIR 2026

Scientific Session

Gastrointestinal Interventions

103 - Pre-clinical in Vivo Study to Assess the Safety and Feasibility of an Innovative Medical Device Called YntraDose in a PDAC CDX Mouse Model Administered Percutaneously

Presenting Author(s)

• 

  Govindarajan Narayanan, MD, FSIR

  Professor and Interventional Radiologist
  Miami Cardiac & Vascular Institute, United States

Author/Co-author(s)

• PH

  Pieter Hossein, MD

  Department of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine
  University of Miami Miller School of Medicine, United States
• RI

  Roberto Iezzi, MD

  Chief of Interventional Radiology Dept at Gemelli Hospital
  Policlinico Gemelli Hospital, Italy
• JG

  Jafar Golzarian, MD

  University of Minnesota, United States
• FR

  Flavio Rochas, MD

  Division Head of Surgical Oncology.
  Oregon Health and Science University., United States
• MM

  Marco Maccauro, MD

  Chief of Nuclear Medicine Dept
  National Istitute of Tumors, Italy
• GD

  Gianluca De Danieli, MD

  Head of Clinical Development Dept
  BetaGlue Therapeutics Spa, Italy
• ML

  Mathias Lukas, PhD

  Medical Physicist
  Charité - Department of Nuclear Medicine, Germany
• NB

  Nicola Beindorff, MD

  Head of Lab, veterinarian
  Charité - BERIC, Germany
• WB

  Winfried Brenner, MD, PhD

  Chair
  Charité - Department of Nuclear Medicine, Germany